Historique
Périodique
Drug treatment programs HCV service delivery to their HCV positive clients
(L'offre de soins pour l'hépatite C dans les programmes de maintenance à destination des usagers positifs au virus de l'hépatite C)
Auteur(s) :
ASTONE TWERELL, J. M. ;
STRAUSS, S. M. ;
HAGAN, H. ;
DES JARLAIS, D. C.
Année
2006
Page(s) :
289-302
Langue(s) :
Anglais
Refs biblio. :
35
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
TRAITEMENT DE MAINTENANCE
;
METHADONE
;
INJECTION
;
USAGER
;
HEPATITE
;
TRAITEMENT
Note générale :
Addiction Research & Theory, 2006, 14, (3), 289-302
Note de contenu :
tabl.
Résumé :
ENGLISH :
Hepatitis C virus (HCV) infection is the most common blood-borne infectious disease among drug users in the US. Drug treatment programs are ideally situated to assist their clients to obtain HCV medical and support services. Using data collected from 233 drug free and methadone maintenance treatment programs (MMTPs) throughout the US, this article examines the range of HCV services that treatment programs provide to their HCV positive clients. Findings indicate that MMTPs offer more comprehensive HCV services to more of their HCV positive clients than drug free programs, although drug free programs provide more individualized services. While 84% of the programs provided some HCV services, there are still serious gaps in the provision of these services (e.g., dealing with medical providers to obtain HCV medication and facilitating access to liver transplant lists). Drug treatment programs need increased funding and staff training to be able to provide comprehensive HCV services to their HCV positive clients. (Author's abstract)
Affiliation :
National Development Res. Inst., 71 West 23rd Str., New York, New York 10010, astonendri.org
Etats-Unis. United States.
Etats-Unis. United States.